fda warning compounding semaglutide september 2025 Important Update: Changes to Compounded Availability July 29, 2024: FDA issued

She is the former chair of a committee of experts that advises FDA leaders about drugs related to endocrinology and metabolism

Inflammatory signaling can extend beyond the respiratory tract and begin disrupting neurological function, gut integrity, metabolic stability, hormonal signaling, and broader immune regulation

This triple mechanism is what makes it potentially more effective for weight loss, and what drives much of the interest in retatrutide among people already using GLP-1 medications

Compounded semaglutide and tirzepatide from telehealth platforms typically come in multi-dose vials with separate syringes